ALS | Costa is a boutique strategic advisory firm specializing in the identification, introduction, and implementation of high-impact, niche medical technologies in complex and highly regulated healthcare markets. Led by Ana Lúcia Santos Costa, ALS | Costa acts as an in-country strategic partner for medical technology companies, supporting them from opportunity assessment through full market execution.

With hands-on experience in innovative and oncologic therapies — including over a decade dedicated to the introduction and development of highly specialized interventional oncology treatments across Brazil and Latin America, with involvement in the early stages of adoption and clinical integration of complex treatment approaches in the region — the firm delivers end-to-end support encompassing regulatory strategy, clinical implementation, stakeholder engagement, logistics orchestration, and early commercialization.

Operating as the client’s eyes, judgment, and strategic presence on the ground, ALS | Costa ensures that breakthrough technologies are introduced in Brazil and Latin America with rigor, precision, and long-term sustainability.